Yamasaki, Y., Honkanen-Scott, M., Hernandez, L., Ikeda, K., Barker, T., Bubb, M.R., Narain, S., Richards, H.B., Chan, E.K., Reeves, W.H. and Satoh, M. (2006) Nucleolar Staining Cannot Be Used as a Screening Test for the Scleroderma Marker Anti-RNA Polymerase I/III Antibodies. Arthritis & Rheumatism, 54, 3051-3056.
http://dx.doi.org/10.1002/art.22043

has been cited by the following article:

• TITLE: Anti-RNA Polymerase III Antibodies in Systemic Sclerosis

  AUTHORS: Andrew Kelly, Chris T. Derk

  KEYWORDS: Autoantibodies, Systemic Sclerosis, Scleroderma, Anti-RNA Polymerase III, Cancer

  JOURNAL NAME: Open Journal of Rheumatology and Autoimmune Diseases, Vol.5 No.3, August 19, 2015

  ABSTRACT: Anti-RNA Polymerase III has been recognized as an important autoantibody in Systemic Sclerosis and it is now included in the 2013 ACR/EULAR classification criteria for Systemic Sclerosis. With this manuscript we attempt to review the current data on anti-RNA polymerase II as it relates to Systemic Sclerosis.